Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[33-year-old woman with upper abdominal pain].
Longerich T, Sommer CM, Schemmer P, Weiss KH. Longerich T, et al. Among authors: weiss kh. Dtsch Med Wochenschr. 2013 May;138(20):1059-60. doi: 10.1055/s-0032-1332937. Epub 2013 May 13. Dtsch Med Wochenschr. 2013. PMID: 23670262 German. No abstract available.
Cardiac volume overload and pulmonary hypertension in long-term follow-up of patients with a transjugular intrahepatic portosystemic shunt.
Wannhoff A, Hippchen T, Weiss CS, Friedrich K, Rupp C, Neumann-Haefelin C, Dollinger M, Antoni C, Stampfl U, Schemmer P, Stremmel W, Weiss KH, Radeleff B, Katus HA, Gotthardt DN. Wannhoff A, et al. Among authors: weiss cs, weiss kh. Aliment Pharmacol Ther. 2016 May;43(9):955-65. doi: 10.1111/apt.13569. Epub 2016 Feb 26. Aliment Pharmacol Ther. 2016. PMID: 26919285 Free article.
Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
Nickkholgh A, Ghamarnejad O, Khajeh E, Tinoush P, Bruckner T, Kulu Y, Mieth M, Goeppert B, Roessler S, Weiss KH, Hoffmann K, Büchler MW, Mehrabi A. Nickkholgh A, et al. Among authors: weiss kh. BJS Open. 2019 Sep 10;3(6):793-801. doi: 10.1002/bjs5.50217. eCollection 2019 Dec. BJS Open. 2019. PMID: 31832586 Free PMC article.
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.
Sangro B, Chan SL, Kelley RK, Lau G, Kudo M, Sukeepaisarnjaroen W, Yarchoan M, De Toni EN, Furuse J, Kang YK, Galle PR, Rimassa L, Heurgué A, Tam VC, Van Dao T, Thungappa SC, Breder V, Ostapenko Y, Reig M, Makowsky M, Paskow MJ, Gupta C, Kurland JF, Negro A, Abou-Alfa GK; HIMALAYA investigators. Sangro B, et al. Ann Oncol. 2024 May;35(5):448-457. doi: 10.1016/j.annonc.2024.02.005. Epub 2024 Feb 19. Ann Oncol. 2024. PMID: 38382875 Free article. Clinical Trial.
211 results